ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes therapeutics. The company operates through three main segments: Rare Disease, which focuses on products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology; Generics, which utilizes R&D expertise and U.S.-based manufacturing; and Established Brands.
